Mark Kidd

20.3k total citations · 6 hit papers
261 papers, 14.4k citations indexed

About

Mark Kidd is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Mark Kidd has authored 261 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Epidemiology, 130 papers in Oncology and 84 papers in Neurology. Recurrent topics in Mark Kidd's work include Neuroendocrine Tumor Research Advances (157 papers), Lung Cancer Research Studies (108 papers) and Neuroblastoma Research and Treatments (82 papers). Mark Kidd is often cited by papers focused on Neuroendocrine Tumor Research Advances (157 papers), Lung Cancer Research Studies (108 papers) and Neuroblastoma Research and Treatments (82 papers). Mark Kidd collaborates with scholars based in United States, Norway and Germany. Mark Kidd's co-authors include Irvin M. Modlin, Kevin D. Lye, Björn Gustafsson, Ignat Drozdov, Lisa Bodei, Anthony Chan, Michael D. Shapiro, Bernhard Svejda, Igor Latich and Michelle N. Zikusoka and has published in prestigious journals such as Science, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Mark Kidd

255 papers receiving 14.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A 5‐decade analysis of 13,715 carcinoid tumors

2003 2.0k citations Irvin M. Modlin, Mark Kidd et al. Cancer profile →
Traces of Human Migrations in Helicobacter pylori Populations

2003 742 citations Daniel Falush, Thierry Wirth et al. Science profile →
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors

2011 632 citations Ben Lawrence, Björn Gustafsson et al. profile →
Current Status of Gastrointestinal Carcinoids

2005 584 citations Irvin M. Modlin, Mark Kidd et al. profile →
Recommendations for management of patients with neuroendocrine liver metastases

2014 349 citations Andrea Frilling, Irvin M. Modlin et al. The Lancet Oncology profile →
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

2014 328 citations Lisa Bodei, Mark Kidd et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Kidd United States	60	10.1k	9.0k	6.0k	2.9k	1.6k	261	14.4k
Irvin M. Modlin United States	71	12.7k 1.3×	11.6k 1.3×	7.8k 1.3×	4.8k 1.7×	2.7k 1.6×	393	20.6k
Anne Couvelard France	68	8.0k 0.8×	9.3k 1.0×	4.5k 0.7×	4.5k 1.6×	1.8k 1.1×	372	15.6k
Guido Rindi Italy	68	15.0k 1.5×	13.5k 1.5×	10.2k 1.7×	3.4k 1.2×	1.8k 1.1×	428	21.6k
Enrico Solcia Italy	72	7.2k 0.7×	6.8k 0.8×	3.3k 0.6×	7.7k 2.7×	3.5k 2.2×	302	18.5k
Donatella Santini Italy	51	2.5k 0.2×	3.5k 0.4×	852 0.1×	2.2k 0.8×	3.0k 1.9×	314	11.0k
Ernest C. Borden United States	66	1.4k 0.1×	5.8k 0.6×	718 0.1×	1.1k 0.4×	4.9k 3.0×	311	16.2k
Bette K. Kleinschmidt‐DeMasters United States	56	3.4k 0.3×	1.6k 0.2×	2.7k 0.4×	1.3k 0.4×	2.7k 1.7×	294	12.4k
Norman Talal United States	62	2.1k 0.2×	2.1k 0.2×	1.2k 0.2×	2.2k 0.8×	3.1k 1.9×	317	27.4k
Tapas K. Das Gupta United States	49	927 0.1×	2.6k 0.3×	1.4k 0.2×	879 0.3×	2.9k 1.8×	287	9.0k
Sirpa Jalkanen Finland	76	1.5k 0.2×	3.1k 0.3×	562 0.1×	1.5k 0.5×	7.7k 4.8×	372	17.9k

Countries citing papers authored by Mark Kidd

Since Specialization

Citations

This map shows the geographic impact of Mark Kidd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Kidd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Kidd more than expected).

Fields of papers citing papers by Mark Kidd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Kidd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Kidd. The network helps show where Mark Kidd may publish in the future.

Co-authorship network of co-authors of Mark Kidd

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Kidd. A scholar is included among the top collaborators of Mark Kidd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Kidd. Mark Kidd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rahbar, Kambiz, et al.. (2025). Clinical Sensitivity and Specificity of the PROSTest in an American Cohort. The Prostate. 85(6). 558–566. 2 indexed citations

Kidd, Mark, Ignat Drozdov, Alin Chirindel, et al.. (2025). NETest ® 2.0—A decade of innovation in neuroendocrine tumor diagnostics. Journal of Neuroendocrinology. 37(4). e70002–e70002. 2 indexed citations

Rosin, R. David, et al.. (2024). Evaluation of a multigenomic liquid biopsy (PROSTest) for prostate cancer detection and follow-up in a Caribbean population. Cancer Epidemiology. 92. 102642–102642. 2 indexed citations

Modlin, Irvin M., Mark Kidd, Ignat Drozdov, et al.. (2024). Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole blood. The Prostate. 84(9). 850–865. 10 indexed citations

Rinke, Anja, Christoph J. Auernhammer, Lisa Bodei, et al.. (2021). Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?. Gut. 70(9). 1768–1781. 24 indexed citations

Jilesen, Anneke P. J., Els J.�M. Nieveen van Dijkum, Heinz‐Josef Klümpen, et al.. (2018). Measurement of circulating transcript levels (NETest) to detect disease recurrence and improve follow‐up after curative surgical resection of well‐differentiated pancreatic neuroendocrine tumors. Journal of Surgical Oncology. 118(1). 37–48. 31 indexed citations

Modlin, Irvin M., Mark Kidd, Pier Luigi Filosso, et al.. (2017). Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms. Journal of Thoracic Disease. 9(S15). S1458–S1473. 10 indexed citations

Risch, Harvey A., Lingeng Lu, Jing Wang, et al.. (2016). Aspirin Use and Reduced Risk of Pancreatic Cancer. Cancer Epidemiology Biomarkers & Prevention. 26(1). 68–74. 50 indexed citations

Kidd, Mark, Ignat Drozdov, & Irvin M. Modlin. (2015). Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status. Endocrine Related Cancer. 22(4). 561–575. 80 indexed citations

10.

Frilling, Andrea, Irvin M. Modlin, Mark Kidd, et al.. (2014). Recommendations for management of patients with neuroendocrine liver metastases. The Lancet Oncology. 15(1). e8–e21. 349 indexed citations breakdown →

11.

Schimmack, Simon, Ben Lawrence, Bernhard Svejda, et al.. (2011). The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms. Cancer. 118(10). 2763–2775. 16 indexed citations

12.

Vázquez‐Carrera, Manuel, Bharat Jasani, Jennifer B. Stott, et al.. (2009). Adenosine A2 receptor signalling mediates chromogranin A secretion from neuroendocrine Tumours. 19. 2 indexed citations

13.

Drozdov, Ignat, et al.. (2009). Nikolai Konstantinovich Kulchitsky (1856–1925). Journal of Medical Biography. 17(1). 47–54. 1 indexed citations

14.

Hauso, Øyvind, Björn Gustafsson, Mark Kidd, et al.. (2008). Neuroendocrine tumor epidemiology. Cancer. 113(10). 2655–2664. 392 indexed citations

15.

Pannala, Rahul, Mark Kidd, & Irvin M. Modlin. (2006). Surgery for Obesity: Panacea or Pandora’s Box?. Digestive Surgery. 23(1-2). 1–11. 7 indexed citations

16.

Falush, Daniel, Thierry Wirth, Bodo Linz, et al.. (2003). Traces of Human Migrations in Helicobacter pylori Populations. Science. 299(5612). 1582–1585. 742 indexed citations breakdown →

17.

Kidd, Mark, et al.. (2001). Conservation of the cag pathogenicity island is associated with vacA alleles and gastroduodenal disease in South African Helicobacter pylori isolates. Gut. 49(1). 11–17. 58 indexed citations

18.

Kidd, Mark, Albert J. Lastovica, John C. Atherton, & J. A. Louw. (1999). Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa?. Gut. 45(4). 499–502. 121 indexed citations

19.

Kidd, Mark & Irvin M. Modlin. (1998). A Century of Helicobacter pylori. Digestion. 59(1). 1–15. 60 indexed citations

20.

Kidd, Mark, et al.. (1997). Dietary factors associated with a low risk of colon cancer in coloured west coast fishermen.. PubMed. 87(2). 152–8. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact